Therapeutic efficacy of oncolytic adenovirus YSCH-01 in osteosarcoma evaluated in PDX and CDX mouse models.

Sci Rep · 2025 · PMC12695983 · PMID 41372267

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In both OS PDX models, YSCH-01 exhibited a highly significant anti-tumor effect at the administration site, with tumor inhibition rates of 155.22% and 170.94%, respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.